Kearns & Associates’s Johnson & Johnson JNJ Stock Holding History

Kearns & Associates’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,400	Closed	-$202K	–	44
2024 Q4	$202K	Hold	1,400	–	–	0.13%	43
2024 Q3	$227K	Hold	1,400	–	–	0.15%	41
2024 Q2	$205K	Hold	1,400	–	–	0.15%	41
2024 Q1	$221K	Hold	1,400	–	–	0.17%	39
2023 Q4	$219K	Hold	1,400	–	–	0.19%	40
2023 Q3	$218K	Hold	1,400	–	–	0.21%	40
2023 Q2	$232K	Hold	1,400	–	–	0.21%	39
2023 Q1	$217K	Hold	1,400	–	–	0.22%	39
2022 Q4	$247K	Buy	+1,400	New	+$242K	0.26%	35

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kearns & Associates's JNJ Position: Q1 2025 in Review

Kearns & Associates sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 1,400 shares — an estimated $202K sold.

Kearns & Associates first reported a position in JNJ in Q4 2022 and held it in 9 quarters. The position peaked at $247K in Q4 2022. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

Kearns & Associates reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
Kearns & Associates sold 1,400 Johnson & Johnson shares in Q1 2025, an estimated $202K.
Kearns & Associates first reported a position in Johnson & Johnson in Q4 2022 and held it in 9 quarters.
Kearns & Associates's Johnson & Johnson position peaked at $247K in Q4 2022.
4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Kearns & Associates's 13F filing for Q1 2025, filed 15 May 2025.